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Background: The purpose of the study is to compare neointimal hyperplasia and
peristent arterial remodeling after implantation of everolimus-eluting stent (EES)
versus sirolimus-eluting stent (SES) using IVUS.
Methods: The study population was a subgroup of 293 patients from the EXCELLENT
trial, a randomized study comparing EES and SES for the treatment of de novo native
coronary artery lesions (total n=1,400, 3:1 randomization). There were 222 patients in
the EES group and 71 patients in the SES group in whom serial IVUS investigation
was performed at pre and post-PCI, and 9-month follow-up.
Results: Baseline clinical and angiographic characteristics were similar between the
two groups. At 9 months, percent neointimal volume obstruction did not differ between
EES and SES (2.67±4.14% vs. 2.27±4.37%, p=0.494). However, percent changes in
vessel volume (3.93±13.49% vs. 8.92±18.46%, p=0.038) and plaque+media (P&M)
volume (3.72±17.28% vs. 10.70±22.14%, p=0.017) within the stented segment were
smaller with EES versus SES. Positive persistent arterial remodeling defined as an
increase in vessel volume >10% (27.0% vs. 42.3%, p=0.015) and late acquired stent
malapposition (4.1% vs. 19.7%, p<0.001) were observed less frequently with EES
versus SES.
Conclusion: EES and SES were similarly effective in reducing neointimal hyperplasia.
However, positive persistent arterial remodeling and late acquired stent malapposition
occurred less frequently with EES.
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Background: Although stent malapposition and incomplete neointimal coverage may
predispose to drug-eluting stents (DES) thrombosis, no data exists regarding the
relationship between the malapposed struts (MS) and uncovered struts (US) on optical
coherence tomography (OCT), especially depending on the extent or portions of
malapposition.
Methods: From Yonsei OCT registry, a total of 306 lesions in 271 patients after DES
implantation were grouped according to the presence of malapposition on follow-up
OCT and then divided into the 3 groups by the median value of % MS (1.3%); the
lesions without malapposition [Group I, (n=232)], with % MS<1.3% [Group II,
(n=37)], and ≥1.3% [Group III, (n=37)]. Percent MS and US were calculated as percent
ratio of MS or US to total struts in the defined cross-sections, respectively. We
compared each % US among these groups, according to the presence of MS.
Results: Group III showed a significantly higher % US in both whole struts and the
struts without malapposition, compared with other groups (See figure). Percent MS
significantly correlated with % US in the struts without malapposition (r=0.494,
p<0.001) as well as in the whole struts (r=0.618, p<0.001). These significant
correlations were only noted in the Group III.
Conclusion: This OCT study demonstrated that DES with malapposition, especially
with a higher % MS, showed a significantly higher incidence of US in the struts without
malapposition, as well as in the whole struts.
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Background: Confirming complete neointimal coverage after drug-eluting stents
(DES) implantation is clinically important, because incomplete stent coverage is the
significant predictor of late stent thrombosis. Previous study using optical coherence
tomography (OCT) demonstrated that stent struts of the first-generation DES still
remain uncovered at mid-term after deployment. On the other hand, 98% of the stent
struts were covered with uniform and thin neointima at 8 months after everolimus-
eluting stent (EES) implantation. However, the time-course up to 3 months analyses
of neointimal coverage in patients with EES (Xience V and PROMUS) has not been
reported. The aim of this study was to evaluate vessel responses at 1, 2 and 3 months
follow-up after EES implantation using OCT.
Methods: A total of 20 stents in 14 patients with de novo native coronary lesions were
enrolled in this study. OCT examination was performed at 1-month (n=7), 2-month
(n=10) and 3-month (n=3) follow-up after EES implantation. Cross-sectional OCT
images were analyzed at 1 mm intervals. The strut apposition to the vessel wall and
neointimal coverage on struts were evaluated by OCT. Mean neointimal hyperplasia
(NIH) thickness was also measured.
Results: The rate of neointimal coverage was 37%, 48% and 60% at 1, 2 and 3-month
follow-up after EES implantation, respectively (Table). The incidence of malapposition
was less than 1%. Intra-stent thrombus was observed in 3 stents among 20 stents.
Conclusion: This study showed that vessel healing was better with second-generation
DES within 3 months after implantation, suggesting that EES might have a favorable
vascular response in relatively early duration.
TCT-688
2 years long-term follow-up optical coherence tomographic findings compared
with 9 months after implantation of everolimus-eluting stents
Jun-Won Lee, Young Jin Youn, Woo-Taek Kim, Sung-Gyun Ahn, Min-Soo Ahn, Jang-
Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon, Kyung-Hoon Choe
Wonju christian hospital, Wonju, Republic of Korea
Background: Late or very late stent thrombosis after drug-eluting stent (DES)
implantation may be related with incomplete neointimal coverage. Optical coherence
tomography (OCT) is valuable modality for the assessment of stent strut coverage. We
evaluated long-term (2 years) effect of everolimus-eluting stent (EES) for tissue
coverage and apposition of stents using OCT compared with 9 months follow-up
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results.
Methods: OCT was evaluated in 30 EESs (28 patients) diagnosed as acute coronary
syndrome. The percent difference of uncovered struts was analyzed according to
follow-up period (9 month vs. 2 year).
Results: Group I (short-term group, 22 lesions in 21 patients) and Group II (long-term
group, 8 lesions in 7 patients) were included in the analysis. The stent diameter and
stent length were no significant differences in both groups (2.94 ± 0.35 vs. 3.06 ± 0.28,
p=0.398; 24.27 ± 8.28 vs. 31.13 ± 13.00, p=0.097, respectively). The area of neointimal
coverage was significantly higher in Group II (11.5 ±4.1 vs. 18.5 ± 5.9, p=0.012) and
the percent of uncovered struts was significantly reduced in Group II (9.7 ± 7.0 vs. 3.0
± 5.2, p=0.019). No differences was shown in malapposed stent struts between both
groups (3.2 ± 8.8 vs. 0.8 ± 1.8, p=0.441).
Figure 1. Frequencies of uncovered struts in optical coherence tomography between
short-term and long-term follow-up group.
Conclusion: Frequent incomplete neointimal coverage was still observed even in new
generation stent (EES) at 9 months. But, uncovered stent struts were significantly
reduced at 2 years follow-up. Further studies are required to determine the clinical
significance of this finding.
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Background: Many scoring systems have been devised in order to identify a pt
population at high risk of primary cardiovascular events. However, whether these
scoring systems can predict secondary events in patients who have established coronary
heart disease is unknown.
Methods: 697 pts with acute coronary syndromes underwent 3-vessel coronary
angiography and radiofrequency intravascular ultrasound after PCI of all culprit lesions
in the PROSPECT trial. Subsequent major adverse cardiovascular events (MACEs:
cardiac death, cardiac arrest, myocardial infarction, or rehospitalization due to unstable
or progressive angina) were adjudicated to be related to either originally treated
(culprit) lesions or untreated (nonculprit) lesions. The median follow-up period was
3.4 yrs. In 419 pts <65 yrs of age, 3 scoring systems - Framingham, PROCAM and
SCORE – were calculated and related to subsequent events.
Results: The 3-year cumulative rate of MACE was 18.3%. Events were adjudicated
as culprit lesion-related in 13.0% and nonculprit lesion-related in 10.5%. The median
(interquartile range) of each scoring system (Framingham, PROCAM, and SCORE)
was 6 (4-8), 39 (32-45,) and 3 (2-5). The quartile distribution of these scores had no
association with total, culprit-associated, or nonculprit-associated MACE. In addition,
no score predicted total (Figure A), culprit-associated (Figure B), or nonculprit-
associated MACE (Figure C).
Conclusion: Conventional risk scores designed to predict primary cardiovascular
events did not work well in patients with pre-existing coronary heart disease presenting
with ACS. Future studies regarding a new scoring system which can predict secondary
cardiovascular events are warranted.
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Background: Age is a major risk factor for atherosclerosis in both sexes. The impact
of age on plaque composition according to gender has not been described.
Methods: After treating all the culprit lesions in 697 patients with acute coronary
syndromes, non-culprit segments and non-culprit lesions (NCLs) were imaged with
gray-scale and virtual histology intravascular ultrasound. We performed an analysis in
younger and older patients (<65 and ≥65 years) with a posterior sex-based sub-analysis-
of plaque morphology, burden and composition.
Results: Lesions in patients ≥65 years vs. <65 years of age were longer (12.6mm vs.
10.8mm, p=0.008) and had slightly greater percentage of plaque burden (48.2% vs.
47.5%, p=0.001), necrotic core (11.0% vs. 12.5%, p=0.001) and dense calcium (4.0%
vs. 5.7%, p<0.0001). Women presented a higher cardiovascular risk profile than men
at all ages. In patients <65 years of age, men compare to women had a greater number
of IVUS-identified NCLs per patient (median 5.00 vs. 4.00, p=0.004) with larger
plaque volumes (47.7mm3 vs. 46.8mm3, p=0.04) and more fibrofatty plaque tissue
(Table). The percentage of younger men with plaque ruptures was also greater than in
women (16.6% vs. 5.1%, p=0.008). In patients ≥65 years of age, the NCLs in women
compared to men had greater necrotic core and dense calcium volume, differences that
were not presented in younger patients.
VH-IVUS Analysis
NC=necrotic core; DC=dense calcium; FT=fibrotic tissue; FF=fibrofatty tissue.
Conclusion: Plaque composition differences between men and women vary according
to age. These observations may provide insights into the different frequencies,
mechanisms and presentations of atherosclerosis in men vs. women at different stages
of life.
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